Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
44 drugs in development
By Therapeutic Area
top 6
R&D Momentum
100/100
Pipeline Velocity
97/100
Trial Completion Rate
74/100
Pipeline Concentration
17/100
Pipeline Freshness
55/100
Strategic Signals
Activity
Last 14 days
Oxytocin as a Neuroendocrine Therapy for Obesity in Youth
LiverPAL: A Randomized Trial of Inpatient Palliative Care for Patients With Advanced Liver Disease
A Study of the Role of Circulating Tumor DNA in Predicting the Likelihood of Organ Preservation or Pathologic Complete Response After Neoadjuvant Therapy for Rectal Cancer
Metabolomic Biomarkers of Myotonic Dystrophy
Celiac Disease Genomic Environmental Microbiome and Metabolomic (CDGEMM) Study
Double Blind, Placebo-controlled Trial to Establish Safety and Efficacy of Ritlecitinib to Prevent Gluten-induced Celiac Enteropathy and Symptoms in Celiac Disease Patients in Remission
Using Mobile Technology to Reduce Stress in Caregivers of Persons With Dementia. A Scalable Solution to a Growing Problem.
Phase II Study of Proton Radiation Therapy for CNS Germ Cell Tumors: Evaluation of Acute and Late Side Effects
Vedolizumab for the Treatment of Collagenous Gastritis
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)